Gender Distribution in Randomized Controlled Trials among Patients with Heart Failure with Reduced Ejection Fraction: A Systematic Review
References
- Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet [Internet]. 2017 Sep 16; 390(10100): 1211–59.
- Yang Y, Carlin AS, Faustino PJ, Motta MIP, Hamad ML, He R, et al. Participation of women in clinical trials for new drugs approved by the Food and Drug Administration in 2000–2002. J Women’s Heal [Internet]. 2009 Mar 1; 18(3): 303–10. Available from:
https://pubmed.ncbi.nlm.nih.gov/19243271/ . DOI: 10.1089/jwh.2008.0971 - Whitelaw S, Sullivan K, Eliya Y, Alruwayeh M, Thabane L, Yancy CW, et al. Trial characteristics associated with under-enrolment of females in randomized controlled trials of heart failure with reduced ejection fraction: A systematic review. Eur J Heart Fail. 2021; 23(1): 15–24. DOI: 10.1002/ejhf.2034
- Tahhan A, Vaduganathan M, Greene S, Alrohaibani A, Raad M, Gafeer M, et al. Enrollment of older patients, women, and racial/ethnic minority groups in contemporary acute coronary syndrome clinical trials: A systematic review. JAMA Cardiol [Internet]. 2020 Mar 25. Available from:
https://scholarlycommons.henryford.com/cardiology_articles/545 . DOI: 10.1001/jamacardio.2020.0359 - Postigo A, Martínez-Sellés M. Sex influence on heart failure prognosis. Front Cardiovasc Med. 2020; 7. DOI: 10.3389/fcvm.2020.616273
DOI: https://doi.org/10.5334/gh.1093 | Journal eISSN: 2211-8179
Language: English
Submitted on: Dec 27, 2021
Accepted on: Dec 27, 2021
Published on: Feb 1, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2022 Asma Gulab, Hani Essa, Kevin Bryan Lo, Rajiv Sankaranarayanan, Janani Rangaswami, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.